Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pharmacia & Upjohn terminates Hemopure codevelopment agreement

July 12, 1996

Results of fat accumulation/PAI-1 levels relationship study disclosed

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor

July 12, 1996

Pfizer and Warner-Lambert sign atorvastatin agreement

July 12, 1996

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Non-steroidal compounds for postmenopausal disorders described by Lilly

July 12, 1996

Low-estrogen oral contraceptives have low stroke risk

July 5, 1996

Oral contraceptive displays cardioprotective effects

July 5, 1996

Ciba-Geigy introduces Noven's Vivelle in Canada

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...